Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2,162 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Management of hepatocellular carcinoma: an update.
Bruix J, Sherman M; American Association for the Study of Liver Diseases. Bruix J, et al. Hepatology. 2011 Mar;53(3):1020-2. doi: 10.1002/hep.24199. Hepatology. 2011. PMID: 21374666 Free PMC article. No abstract available.
Hepatocellular carcinoma.
Sherman M. Sherman M. Gastroenterologist. 1995 Mar;3(1):55-66. Gastroenterologist. 1995. PMID: 7538016 Review.
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.
Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodés J; EASL Panel of Experts on HCC. Bruix J, et al. J Hepatol. 2001 Sep;35(3):421-30. doi: 10.1016/s0168-8278(01)00130-1. J Hepatol. 2001. PMID: 11592607 No abstract available.
Regorafenib for treatment of hepatocellular carcinoma.
Sherman M. Sherman M. Hepatology. 2018 Mar;67(3):1162-1165. doi: 10.1002/hep.29598. Epub 2018 Jan 24. Hepatology. 2018. PMID: 29059458 No abstract available.
Whither hepatocellular carcinoma screening?
Sherman M. Sherman M. Hepatology. 2012 Dec;56(6):2412-4. doi: 10.1002/hep.26138. Hepatology. 2012. PMID: 23212776 No abstract available.
Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.
Doyle A, Gorgen A, Muaddi H, Aravinthan AD, Issachar A, Mironov O, Zhang W, Kachura J, Beecroft R, Cleary SP, Ghanekar A, Greig PD, McGilvray ID, Selzner M, Cattral MS, Grant DR, Lilly LB, Selzner N, Renner EL, Sherman M, Sapisochin G. Doyle A, et al. J Hepatol. 2019 May;70(5):866-873. doi: 10.1016/j.jhep.2018.12.027. Epub 2019 Jan 5. J Hepatol. 2019. PMID: 30615906
Hepatocellular carcinoma.
Llovet JM, Zucman-Rossi J, Pikarsky E, Sangro B, Schwartz M, Sherman M, Gores G. Llovet JM, et al. Nat Rev Dis Primers. 2016 Apr 14;2:16018. doi: 10.1038/nrdp.2016.18. Nat Rev Dis Primers. 2016. PMID: 27158749 Review.
Wait Time for Curative Intent Radio Frequency Ablation is Associated with Increased Mortality in Patients with Early Stage Hepatocellular Carcinoma.
Brahmania M, Ahmed O, Kelley M, Wong D, Kowgier M, Khalili K, Beecroft R, Renner EL, Shah H, Feld J, Janssen HLA, Sherman M. Brahmania M, et al. Ann Hepatol. 2017 Sep-Oct;16(5):765-771. doi: 10.5604/01.3001.0010.2776. Ann Hepatol. 2017. PMID: 28809734
Health care costs associated with hepatocellular carcinoma: a population-based study.
Thein HH, Isaranuwatchai W, Campitelli MA, Feld JJ, Yoshida E, Sherman M, Hoch JS, Peacock S, Krahn MD, Earle CC. Thein HH, et al. Hepatology. 2013 Oct;58(4):1375-84. doi: 10.1002/hep.26231. Epub 2013 Mar 15. Hepatology. 2013. PMID: 23300063
Optimization of imaging diagnosis of 1-2 cm hepatocellular carcinoma: an analysis of diagnostic performance and resource utilization.
Khalili K, Kim TK, Jang HJ, Haider MA, Khan L, Guindi M, Sherman M. Khalili K, et al. J Hepatol. 2011 Apr;54(4):723-8. doi: 10.1016/j.jhep.2010.07.025. Epub 2010 Sep 22. J Hepatol. 2011. PMID: 21156219 Clinical Trial.
2,162 results
Jump to page
Feedback